University Of Texas/texas Am Investment Management Co sold $85k of RNTX
owner at Aileron Therapeutics, Inc.. 20,315 shares at an average of $4.21, traded May 1, 2024, filed May 14, 2024.
Score components
- +12Role10% owner
- +9Trade size$85k at market
- 0Share of holdings soldSold 1.1% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -16.7%, 3m -47.2%, 6m -1.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001019231-24-000023, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 1, 2024 | SOpen-market sale Common Stock | -3,100 | $4.10 | $13k | 1,807,357 | May 14, 2024 |
| May 1, 2024 | SOpen-market sale Common Stock | -100 | $4.11 | $411 | 1,807,257 | May 14, 2024 |
| May 1, 2024 | SOpen-market sale Common Stock | -1,750 | $4.12 | $7,210 | 1,805,507 | May 14, 2024 |
| May 1, 2024 | SOpen-market sale Common Stock | -380 | $4.13 | $1,569 | 1,805,127 | May 14, 2024 |
| May 1, 2024 | SOpen-market sale Common Stock | -1,600 | $4.15 | $6,632 | 1,803,527 | May 14, 2024 |
| May 1, 2024 | SOpen-market sale Common Stock | -670 | $4.15 | $2,781 | 1,802,857 | May 14, 2024 |
| May 1, 2024 | SOpen-market sale Common Stock | -400 | $4.18 | $1,672 | 1,802,457 | May 14, 2024 |
| May 1, 2024 | SOpen-market sale Common Stock | -7,923 | $4.25 | $34k | 1,794,534 | May 14, 2024 |
| May 1, 2024 | SOpen-market sale Common Stock | -310 | $4.26 | $1,321 | 1,794,224 | May 14, 2024 |
| May 1, 2024 | SOpen-market sale Common Stock | -317 | $4.27 | $1,352 | 1,793,907 | May 14, 2024 |
| May 1, 2024 | SOpen-market sale Common Stock | -100 | $4.27 | $427 | 1,793,807 | May 14, 2024 |
| May 1, 2024 | SOpen-market sale Common Stock | -200 | $4.28 | $855 | 1,793,607 | May 14, 2024 |
| May 1, 2024 | SOpen-market sale Common Stock | -337 | $4.28 | $1,442 | 1,793,270 | May 14, 2024 |
| May 1, 2024 | SOpen-market sale Common Stock | -200 | $4.29 | $857 | 1,793,070 | May 14, 2024 |
| May 1, 2024 | SOpen-market sale Common Stock | -2,903 | $4.29 | $12k | 1,790,167 | May 14, 2024 |
| May 1, 2024 | SOpen-market sale Common Stock | -25 | $4.32 | $108 | 1,790,142 | May 14, 2024 |
Related signals
Other insiders at Aileron Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 50Moderate | RNTXbuy Aileron Therapeutics, Inc. | Josef H Von Rickenbach director | $50k 47,060 shares | +305% | |
| 38Weak | RNTXbuy Aileron Therapeutics, Inc. | James Brian Windsor See Remarks | $25k 25,000 shares | +1222% | |
| 26Weak | RNTXbuy Aileron Therapeutics, Inc. | Voss Capital, LLC owner | $128k 104,183 shares | +13% | |
| 29Weak | RNTXbuy Aileron Therapeutics, Inc. | Voss Capital, LLC owner | $423k 306,050 shares | +44% | |
| 33Weak | RNTXbuy Aileron Therapeutics, Inc. | James Brian Windsor President and CEO | $898 400 shares | - | |
| 12Weak | RNTXsell Aileron Therapeutics, Inc. | University Of Texas/texas Am Investment Management Co owner | $22k 6,607 shares | -0% | |
| 21Weak | RNTXsell Aileron Therapeutics, Inc. | University Of Texas/texas Am Investment Management Co owner | $81k 24,671 shares | -1% | |
| 18Weak | RNTXsell Aileron Therapeutics, Inc. | University Of Texas/texas Am Investment Management Co owner | $41k 12,315 shares | -1% | |
| 23Weak | RNTXsell Aileron Therapeutics, Inc. | University Of Texas/texas Am Investment Management Co owner | $139k 31,151 shares | -2% | |
| 37Weak | RNTXbuy Aileron Therapeutics, Inc. | James Brian Windsor President and COO | $758 225 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.